Related Experiment Videos
MPO-ANCA-associated small vessel vasculitis presenting as fever of unknown origin. Report of one case
Harun Akar1, Cigdem Ozbasli-Levi, Taskin Senturk
1Department of Nephrology, Adnan Menderes University Medical School, Aydin, Turkey. hakar2002@hotmail.com
Abstract:
Microscopic polyangiitis (MPA) is an antineutrophil cytoplasmic antibody (ANCA) associated small vessel vasculitis which can present with various clinical manifestations, for which the mainstay of treatment is systemic corticosteroids and immunosuppressants. We report a case of a 54-year-old female admitted to the hospital because of fever during the last month, leukocytosis and elevated erythrocyte sedimentation rate. Persistence of elevated serum creatinine levels and accompanying hematuria led us to perform a renal biopsy, and MPA was diagnosed on the basis of light and immunofluorescence microscopy. Remission was induced with oral corticosteroids and cyclophosphamide therapy in conjunction with plasmapheresis (PF). The objective of this report was to assess the role of PF in the treatment of MPA and report on its utility in patients with MPA who are not responding to standard therapy or who require unacceptably high doses of steroids or immunosuppressants. In a patient presenting with fever of unknown origin, microscopic polyangiitis should also be considered in the differential diagnosis.
Insights
Microscopic polyangiitis (MPA), an ANCA-associated vasculitis, can be treated with corticosteroids and immunosuppressants. Plasmapheresis (PF) showed utility in a refractory MPA case, aiding remission when standard therapies were insufficient.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Microscopic polyangiitis (MPA) is a small vessel vasculitis associated with antineutrophil cytoplasmic antibodies (ANCAs).
- Standard treatment involves corticosteroids and immunosuppressants, but some patients exhibit refractory disease or require high-dose therapy.
- Fever, leukocytosis, elevated ESR, rising creatinine, and hematuria are key indicators for MPA investigation.
Observation:
- A 54-year-old female presented with prolonged fever, leukocytosis, and elevated ESR.
- Persistent renal dysfunction and hematuria prompted a renal biopsy, confirming MPA via microscopy.
- The patient achieved remission with corticosteroids, cyclophosphamide, and plasmapheresis (PF).
Findings:
- This case highlights the successful use of plasmapheresis in conjunction with standard immunosuppressive therapy for MPA.
- Plasmapheresis was instrumental in inducing remission in a patient with refractory disease.
- The study assesses the role and utility of PF in MPA management, particularly for non-responders or those needing high-dose conventional treatments.
Implications:
- Plasmapheresis may be a valuable therapeutic option for select patients with microscopic polyangiitis who do not respond adequately to conventional treatments.
- Considering MPA in the differential diagnosis of fever of unknown origin with renal involvement is crucial.
- This case expands the understanding of treatment strategies for ANCA-associated vasculitis, emphasizing personalized therapeutic approaches.
Related Concept Videos
Arboviral Encephalitis
Viral Meningitis
Atypical Pneumonia
Encephalitis l: Introduction
Poliomyelitis
Bacterial Meningitis